← All trials
NCT04783311
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 23, 2021
- Primary completion
- Mar 31, 2022
- Completion date
- Jan 31, 2023
- First posted
- Mar 5, 2021
- Last posted
- Apr 26, 2021
- Enrollment
- 280
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- EuBiologics Co.,LtdLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.